
Pembrolizumab-Based Regimens Gain Ground in TNBC Management
Evolving early-stage triple-negative breast cancer (TNBC) treatment approaches underscore the importance of precision medicine and ongoing research to improve outcomes for patients with this malignancy, who have historically had poor prognoses, according …